Agilent Technologies (NYSE:A) Releases FY 2021 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its FY 2021 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $4.280-$4.310 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.140. The company issued revenue guidance of $6.29 billion-$6.32 billion, compared to the consensus revenue estimate of $6.22 billion.Agilent Technologies also updated its Q4 2021 guidance to $1.150-$1.180 EPS.

A has been the topic of a number of recent research reports. SVB Leerink lifted their target price on shares of Agilent Technologies from $160.00 to $170.00 and gave the company an outperform rating in a report on Wednesday, August 18th. Robert W. Baird upped their target price on shares of Agilent Technologies from $144.00 to $170.00 and gave the stock an outperform rating in a research report on Wednesday, August 18th. raised their target price on shares of Agilent Technologies from $150.00 to $160.00 and gave the company a buy rating in a report on Wednesday, May 26th. KeyCorp upped their target price on shares of Agilent Technologies from $160.00 to $195.00 and gave the company an overweight rating in a report on Wednesday, August 18th. Finally, Wells Fargo & Company boosted their price objective on shares of Agilent Technologies from $150.00 to $180.00 and gave the company an overweight rating in a research report on Wednesday, August 18th. Two analysts have rated the stock with a hold rating and twenty-two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of Buy and an average price target of $138.77.

Shares of Agilent Technologies stock opened at $172.42 on Wednesday. The stock has a market cap of $52.20 billion, a PE ratio of 53.88, a price-to-earnings-growth ratio of 3.17 and a beta of 1.00. Agilent Technologies has a 12 month low of $95.44 and a 12 month high of $179.57. The company has a quick ratio of 1.63, a current ratio of 2.11 and a debt-to-equity ratio of 0.55. The business has a fifty day simple moving average of $161.23 and a 200-day simple moving average of $143.09.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Monday, August 16th. The medical research company reported $1.10 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.99 by $0.11. Agilent Technologies had a net margin of 16.12% and a return on equity of 26.12%. The firm had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.54 billion. During the same quarter in the prior year, the business earned $0.78 EPS. The company’s revenue for the quarter was up 25.8% compared to the same quarter last year. Analysts expect that Agilent Technologies will post 4.31 EPS for the current fiscal year.

In related news, SVP Dominique Grau sold 1,968 shares of the company’s stock in a transaction on Thursday, June 17th. The shares were sold at an average price of $145.10, for a total transaction of $285,556.80. Following the completion of the transaction, the senior vice president now directly owns 83,388 shares in the company, valued at approximately $12,099,598.80. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Over the last quarter, insiders have sold 20,034 shares of company stock valued at $3,176,659.

An institutional investor recently raised its position in Agilent Technologies stock. Morgan Stanley lifted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 2.9% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,154,775 shares of the medical research company’s stock after acquiring an additional 33,059 shares during the quarter. Morgan Stanley owned approximately 0.38% of Agilent Technologies worth $170,688,000 at the end of the most recent reporting period.

Agilent Technologies Company Profile

Agilent Technologies, Inc engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets; Diagnostics and Genomics; and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level.

See Also: What is intrinsic value?

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.